Submit or Track your Manuscript LOG-IN

Evaluation of Novel Anti-VEGF Molecules in the Animal Model of Human Lung Cancer

Evaluation of Novel Anti-VEGF Molecules in the Animal Model of Human Lung Cancer

Sanjukta Chakrabarti1, Colin J. Barrow2, Rupinder K. Kanwar3, Venkata Ramana1*, Rakesh N. Veedu4,5 and Jagat R. Kanwar3* 

Figure 1

Structure of the aptamer, RNV66 (Edwards, S.L. et al. Chemical Communications; 2015) LNA stands for locked nucleic acid. It is a novel class of high-affinity RNA analogue in which the ribose ring is locked by a methylene bridge to 3’-endo conformation, giving it very high thermal stability. The aptamer RNV66 contains 3 LNA bases. 

Figure 2

Immunohistochemistry scheme with different methods of antigen detection. 

Figure 3a

Tumor growth curve in response to anti-angiogenic treatment 

Figure 3b

Plot of mean tumor volume in SCID mice versus duration of treatment with 15 mg/kg dose of anti-VEGF molecules. 

Figure 4

In vivo therapeutic efficacy of VEGFR1(D1-D3)-Fc to reduce xenograft tumor in SCID mice model. 

Figure 5

In vivo therapeutic efficacy of aptamer, RNV66 to reduce xenograft tumor in SCID mice model. 

Figure 6

Representative images of histological sections of tumors.
(A, B) Images of C-1 and C-2 which represent sections from control (untreated) tumors; (C, D) Images of P-1 and P-2 which represent
placebo-treated tumors; (E, F) Images of A-3 and A-4 which represent aflibercept-treated tumors; (G, H) Images of V3 and V-4 which represent
VEGFR1(D1-D3)-Fc-treated tumors. (I) Image of RNV66#3, which represents aptamer-treated tumor in animal#3; (J) Image of
VEGFR1(D1-D3)-Fc and RNV66# 5, which represents animal#5 which received a combination of VEGFR1(D1-D3)-Fc and aptamer, as
treatment. Arrow heads indicate tumor cells in a pool of normal cells 

Figure 7

Ki-67 staining of tumor sections. 

Figure 8a

Representative images of immunofluorescence staining of CD31 in mouse vasculature in tumor sections.
(A) Untreated control (B) Placebo-treated (C) VEGFR1(D1-D3)-Fc-treated (D) Aflibercept-treated (E) RNV66-treated (F) VEGFR1(
D1-D3)-Fc plus RNV66-treated tumor. All images were captured in high power field, under 40 x magnification. Scale bar=100μm. 

Figure 8b

Graph showing microvessel density (MVD)
of tumor vasculature.
***, p≤0.001; ****, p≤0.0001 

Pakistan Journal of Zoology

November

Pakistan J. Zool., Vol. 56

Featuring

Click here for more

Subscribe Today

Receive free updates on new articles, opportunities and benefits


Subscribe Unsubscribe